scispace - formally typeset
Journal ArticleDOI

Cancer survival corrected for heterogeneity in patient withdrawal.

Timo Hakulinen
- 01 Dec 1982 - 
- Vol. 38, Iss: 4, pp 933-942
Reads0
Chats0
TLDR
A method based on the concept of an 'expected life table' is proposed for removal of the bias and it is suggested that the practical performance of the proposed method is better than that of other alternatives, even when the relative survival rates in the subgroups are not equal.
Abstract
Survival from cancer over a certain time period is often measured by the 'relative survival rate'. This is the ratio of the observed survival rate in the group of patients to the survival rate expected in a group of people in the general population, who are similar to the patients with respect to all of the possible factors affecting survival at the beginning of the period, except for the disease under study. When patterns of patient withdrawal differ for a number of subgroups of patients with equal relative survival rates, the current method of derivation of the relative survival rate is biased. A method based on the concept of an 'expected life table' is proposed for removal of the bias. Examples based on material from the Finnish Cancer Registry suggest that the practical performance of the proposed method is better than that of other alternatives, even when the relative survival rates in the subgroups are not equal.

read more

Citations
More filters
Journal ArticleDOI

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

TL;DR: Age-adjusted 5-year period survival improved for patients diagnosed in 2000-02, especially for patients with colorectal, breast, prostate, and thyroid cancer, Hodgkin's disease, and non-Hodgkin lymphoma, although, patients in eastern European had the highest improvement in survival for major cancer sites during 1991-2002.
Journal ArticleDOI

EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

TL;DR: EUROCARE-3 as mentioned in this paper analyzed the survival of 1815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries and found that survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain).
Journal ArticleDOI

EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

TL;DR: Survival for most solid cancers, whose prognosis depends largely on stage at diagnosis, was highest in Finland, Sweden, Norway and Iceland, lower in the UK and Denmark, and lowest in the Czech Republic, Poland and Slovenia.
Related Papers (5)